Press releases March 30, 2020 Compass Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy and Safety of CTX-471, a Unique Fully Human Agonist of CD137 February 28, 2020 Compass Therapeutics to Present at the 40th Cowen Health Care Conference January 6, 2020 Compass Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
